| Product Name | MF | CAS | Details |
|---|
| VU0531245 | C17H17N3O4S2 | 1396749-92-0 | Details |
| VU661 | C19H13N3O | 37648-76-3 | Details |
| WAY-299765 | C13H9NO2S | 106578-02-3 | Details |
| XSJ2-46 | 2265911-12-2 | Details |
| YG1702 | C23H30N2O7S | 724737-08-0 | Details |
| YS-363 | C30H30N4O3 | 2470908-90-6 | Details |
| Z-FG-NHO-BzOME | C27H27N3O7 | 180313-86-4 | Details |
| ZH8659 | C12H13NO | 885466-70-6 | Details |
| ZINC49534341 | C12H9N3OS2 | 1274013-03-4 | Details |
| Z-LVG | C21H31N3O6 | 119670-31-4 | Details |
| Zndm19 | C13H13N3OS2 | 364055-05-0 | Details |
| Oxynitidine | C21H17NO5 | 548-31-2 | Details |
| Atrosab | 1365659-05-7 | Details |
| N-Acetyl-L-arginine | C8H16N4O3 | 155-84-0 | Details |
| Keap1-Nrf2-IN-16 | C73H114N16O26 | 1362661-40-2 | Details |
| GRK2 Inhibitor 2 | C19H16N4O2 | 2592436-21-8 | Details |
| Cyclophellitol aziridine | C7H13NO4 | 136861-97-7 | Details |
| ON 108600 | C22H14Cl2N2O6S2 | 1585246-23-6 | Details |
| Cbl-b-IN-13 | C29H30F3N5O2 | 2368841-85-2 | Details |
| Cbl-b-IN-12 | C28H29F3N6O2 | 2851871-29-7 | Details |
| Cbl-b-IN-11 | C31H35F5N6O | 2815225-15-9 | Details |
| Cbl-b-IN-10 | C31H37F3N6O | 2815225-12-6 | Details |
| Cbl-b-IN-9 | C30H33F3N6O2 | 2815223-41-5 | Details |
| Cbl-b-IN-8 | C35H44F3N7O3 | 2815223-33-5 | Details |
| Cbl-b-IN-7 | C29H31F4N5O2 | 2815221-35-1 | Details |
| Cbl-b-IN-6 | C30H32F5N5O | 2815221-33-9 | Details |
| Androgen receptor degrader-3 | C45H51ClN8O5 | 2753650-84-7 | Details |
| HSD17B13-IN-3 | C22H21NO6S2 | 313259-88-0 | Details |
| HSD17B13-IN-2 | C21H23F2NO4 | 863564-24-3 | Details |
| 9-Chloromethyl-10-hydroxy-11-F-Camptothecin | C22H18ClFN2O4 | 2414594-22-0 | Details |
| JAK-IN-31 | 2597016-88-9 | Details |
| CDK7-IN-25 | 2009209-60-1 | Details |
| FGFR4-IN-16 | 1970120-44-5 | Details |
| HBV-IN-38 | 1834483-86-1 | Details |
| EDI048 | C25H21ClN4O4 | 2767264-57-1 | Details |
| m-Se3 | C29H23N2Se.I | 2829939-44-6 | Details |
| Zevotrelvir | C28H26F3N5O3 | 2773516-53-1 | Details |
| Votoplam | C21H25N9O | 2407849-89-0 | Details |
| Tibremciclib | C28H32F2N8 | 2397678-18-9 | Details |
| Tacaciclib | C30H36N6O3 | 2768774-66-7 | Details |
| Risevistinel | C14H23N3O4 | 2591344-26-0 | Details |
| Nevadistinel | C15H18N2O3 | 2181816-92-0 | Details |
| Lacutoclax | C48H55ClN8O7S | 2291166-56-6 | Details |
| Igermetostat | C32H46N4O4 | 2409538-60-7 | Details |
| Icalcaprant | C23H26N4O3 | 2227384-17-8 | Details |
| Frunexian | C19H26N4O4 | 1803270-60-1 | Details |
| Friluglanstat | C25H20ClF3N4O3 | 1422203-86-8 | Details |
| Anticancer agent 144 | 2948340-59-6 | Details |
| Anticancer agent 143 | C19H15BrF2N3O6PS2 | 2948339-38-4 | Details |
| Anticancer agent 142 | C13H14BrF2N2O7PS2 | 2948338-60-9 | Details |
| Cinsebrutinib | 2724962-58-5 | Details |
| Bocodepsin hydrochloride | C26H39N5O6S2.ClH | 1834513-66-4 | Details |
| Bocodepsin | C26H39N5O6S2 | 1834513-65-3 | Details |
| (S)-Bexicaserin | C15H19F2N3O | 2035818-21-2 | Details |
| Bavtavirine | C26H20N6 | 1956373-71-9 | Details |
| Arbemnifosbuvir | C24H33FN7O7P | 1998705-63-7 | Details |
| Aneratrigine | C19H20ClF2N5O2S2 | 2097163-74-9 | Details |
| ROCK-IN-9 | C20H20FN5O2 | 2643334-76-1 | Details |
| DGKα-IN-7 | C23H17F5N6 | 2886092-50-6 | Details |
| DGKα-IN-6 | C25H21F3N6 | 2886734-91-2 | Details |
| DGKα&ζ-IN-1 | C29H31FN8O2 | 2830643-06-4 | Details |
| AMB639752 | C21H23N3O3 | 371210-26-3 | Details |
| S1P1 agonist 6 hemicalcium | 2941310-03-6 | Details |
| S1P1 agonist 6 | 2433782-42-2 | Details |
| c-Fms-IN-14 | 1898210-99-5 | Details |
| pan-KRAS-IN-3 | C33H32F3N5O2 | 2875116-29-1 | Details |
| BTK-IN-27 | 1841502-36-0 | Details |
| Porcn-IN-2 | C24H17F3N6O | 1900754-65-5 | Details |
| ROCK-IN-8 | 1621103-79-4 | Details |
| JAK kinase-IN-1 | C17H19F2N7OS | 2698389-43-2 | Details |
| 5-HT2A&5-HT2C agonist-1 | 1640-02-4 | Details |
| 5-HT2 agonist-1 free base | 2708279-77-8 | Details |
| 5-HT2 agonist-1 | C19H22N2O2.ClH | 2708279-78-9 | Details |
| 5-HT2C agonist-3 free base | 2104810-17-3 | Details |
| 5-HT2C agonist-3 | C19H22FNO2.ClH | 2104810-18-4 | Details |
| pan-KRAS-IN-2 | C34H34F2N4O3 | 2882825-14-9 | Details |
| pan-KRAS-IN-4 | 2885961-55-5 | Details |
| PHD-IN-2 | 2924182-42-1 | Details |
| PHD-IN-1 | 2924182-31-8 | Details |
| USP1-IN-6 | C29H27F3N8O | 2925547-95-9 | Details |
| USP1-IN-5 | C27H23F3N8O | 2925547-94-8 | Details |
| TNIK&MAP4K4-IN-1 | C25H23FN4O3 | 2478592-86-6 | Details |
| CRF1 receptor antagonist-1 | 2635364-30-4 | Details |
| αvβ1 integrin-IN-2 | C29H38N4O4 | 2234874-68-9 | Details |
| Immunosuppressant-1 | C14H12BrNO3 | 1224571-03-2 | Details |
| HPK1-IN-38 | 2578802-72-7 | Details |
| HPK1-IN-37 | C27H35N7O4 | 2766481-68-7 | Details |
| Laxiflorin B | C20H24O5 | 165337-71-3 | Details |
| Antibacterial agent 159 | C51H50N16O10S6 | 2804044-53-7 | Details |
| Antibacterial agent 158 | 2804045-21-2 | Details |
| HBV-IN-41 | 1967002-25-0 | Details |
| Tubulin polymerization-IN-52 | 2108615-05-8 | Details |
| BQZ-485 | C32H39NO3 | 1906915-49-8 | Details |
| Beclin1-ATG14L interaction inhibitor 1 | C23H24N4O5S | 1243063-73-1 | Details |
| hCAIX/XII-IN-8 | 59994-64-8 | Details |
| GPR55 agonist 3 | C19H16F4N4 | 3006105-44-5 | Details |
| TRK-IN-24 | 2937544-01-7 | Details |
| FIKK9.1-IN-1 | 1448523-50-9 | Details |
| SIRT6-IN-3 | C21H29Br2N6S.Br.ClH | 3023471-40-8 | Details |
| RET-IN-25 | 2965703-02-8 | Details |
| Product Total： Product Page： | ||||
| 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 | ||||